glp-1 dual agonist Trends in the Development of Receptor Agonists PDB-101: Molecule of the Month:

We searched for approved generic competitors in the Orange Book to determine if the expected duration of protection for brand-name products had been cut short by early generic competition, and we used the FDAs Paragraph IV Certifications List (updated through the end of 2022) to identify patent challenges on brand-name products in the cohort

GLP-1 agonists work by mimicking the effects of this hormone, resulting in several beneficial metabolic actions: Stimulate insulin secretion from the pancreas in response to meals Suppress appetite by acting on appetite centers in the brain Slow gastric emptying , which helps prolong satiety after eating Reduce glucagon secretion , helping to lower blood sugar levels Together, these effects make GLP-1 agonists an effective tool not only for diabetes management but also for sustainable, medically supervised weight loss

Mary Hatch noted that the significance of making GLP-1 more accessibile

Use of dipeptidyl peptidase-4 inhibitors for type 2 diabetes mellitus and risk of fracture